Unknown

Dataset Information

0

Anti-osteoporosis Medication Use in a High Fracture-Risk Population: Contemporary Trends in Australian Residential Aged Care Facilities.


ABSTRACT: Osteoporotic fractures impose substantial morbidity and mortality among older adults. Undertreatment is an ongoing concern; treatment rates declined following reports of adverse effects of guideline-recommended bisphosphonates, but new antiresorptives have since become available. Our goal was to identify contemporary trends in osteoporosis treatment guideline adherence in a high fracture-risk population. We conducted a secondary data analysis using electronic health record data of adults aged ?65?years from 68 residential aged care facilities in Australia during 2014-2017 (n?=?9094). Using medication administration data, we identified antiresorptive (bisphosphonates and denosumab) and vitamin D supplement use among residents with osteoporosis. Regression was used to evaluate temporal trends, and resident and facility characteristics associated with antiresorptive use and vitamin D use. In 2014, 34% of women and 42% of men with osteoporosis used antiresorptives; this decreased 8?percentage points by 2017. Antiresorptive use was higher among those with a history of fracture and lower in the last year of life. Denosumab use increased but did not substitute for the continued decline in bisphosphonate use. Vitamin D was consistently used by more than 60% of residents and was higher among those with fracture history. Greater attention to the treatment of osteoporosis treatment rates among this high fracture-risk population is warranted.

SUBMITTER: Lind KE 

PROVIDER: S-EPMC6547170 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Anti-osteoporosis Medication Use in a High Fracture-Risk Population: Contemporary Trends in Australian Residential Aged Care Facilities.

Lind Kimberly E KE   Jorgensen Mikaela L ML   Gray Leonard C LC   Georgiou Andrew A   Westbrook Johanna I JI  

Health services insights 20190602


Osteoporotic fractures impose substantial morbidity and mortality among older adults. Undertreatment is an ongoing concern; treatment rates declined following reports of adverse effects of guideline-recommended bisphosphonates, but new antiresorptives have since become available. Our goal was to identify contemporary trends in osteoporosis treatment guideline adherence in a high fracture-risk population. We conducted a secondary data analysis using electronic health record data of adults aged ⩾6  ...[more]

Similar Datasets

| S-EPMC10652444 | biostudies-literature
| S-EPMC10083958 | biostudies-literature
| S-EPMC5553921 | biostudies-other
| S-EPMC9774757 | biostudies-literature
| S-EPMC3547703 | biostudies-literature
| S-EPMC10625226 | biostudies-literature
| S-EPMC4287675 | biostudies-literature
| S-EPMC7246482 | biostudies-literature
| S-EPMC10604517 | biostudies-literature
| S-EPMC10463348 | biostudies-literature